TTNP TITAN PHARMACEUTICALS INC Accounting Changes 8-K Filing 2024 - Restatement of Financial Statements Titan Pharmaceuticals Inc restates financial statements for the quarterly period ended September 30, 2023 due to an error in accounting, resulting in a material weakness in internal control over financial reporting.Get access to all SEC 8-K filings of the TITAN PHARMACEUTICALS INC